Patient Protection and Affordable Care Act (PPACA); Oregon Emerging Infections Pr

患者保护和平价医疗法案 (PPACA)；

• 批准号: 8151004
• 负责人: Paul R Cieslak
• 金额: $ 28.77万
• 依托单位: PUBLIC HEALTH SERVICES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-30 至 2012-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8151004
• 关键词: Patient; Protection; Affordable; Care; Act

DESCRIPTION (provided by applicant): The purpose of CDC's 10-state Emerging Infections Program (EIP) is to conduct surveillance and epidemiologic studies that go beyond the routine functions of most health departments, to answer questions of national public-health importance, and to train future epidemiologists. The purpose of this Affordable Care Act funding is to support and extend the capabilities of existing EIP sites, as well as to initiate new projects related to influenza and healthcare-acquired infections (HAIs). PPACA funding will be used by the Oregon Public Health Division to enhance support for the basic infrastructure of the EIP network, currently in place in Oregon. These funds will serve to support personnel currently working on EIP-related projects, offer training and education to various stakeholders, expand on the information technology and exchange efforts within our state and nationally, and to conduct the new projects. Specifically, funds will be spent on 4 focus areas: 1) Hire an additional 3.0 FTE to support multiple EIP activities. 2) Obtain education and training in relevant surveillance and epidemiologic areas - viz., infection control and health information. Up to eight EIP personnel will receive additional education and training in infection control, and up to 15 EIP personnel will receive advanced education and training in health information practices. 3) Support information technology to allow the capture of data regarding bloodstream infections from hemodialysis centers in the Portland metropolitan area. 4) Hire 1.75 FTE to enhance the general epidemiology and laboratory capacity related to HAIs and influenza. Oregon's EIP will work to establish a standard for evaluation and validation of surveillance for bloodstream infections. Additionally, the use of PCR for typing/subtyping of isolates from hospitalized patients with influenza within the Portland metropolitan EIP catchment area will both enhance the epidemiology and laboratory capacity of influenza in Oregon. Furthermore, the EIP influenza program will carry out a study to refine influenza burden projections in the state of Oregon. New stakeholders involved will be the hemodialysis centers that will be requested to submit positive blood stream infections notifications to ACDP. All other efforts undertaken by this funding opportunity will go toward sustaining and enhancing practices currently in place with longstanding EIP stakeholders (i.e. the Oregon State Public Health Laboratory) Proposed new staffing will include 1.0 FTE supervisory Research Analyst-4; 2.5 FTE Research Analyst 2; 1.0 FTE Administrative Specialist-2; and 0.25 FTE Microbiologist-2. The PPACA EIP funding furthers the OHA mission of keeping Oregonians healthy and safe through enhancement of communicable disease surveillance systems that promote early identification of outbreaks and improve the quality of data needed for priority setting, policy development, and prevention and control of infectious diseases. Most of the projects with the EIP do not constitute human subjects research. For any projects that involve research in human subjects, Oregon's EIP program will submit protocols to the Oregon Public Health Division Institutional Review Board. Summary data (i.e., without patient identifiers) will be shared with CDC and through local and national publications of public health merit. PUBLIC HEALTH RELEVANCE: The purpose of this Affordable Care Act funding through the Emerging Infections Program (EIP) is to support state and local health departments' surveillance infrastructure through enhancement of the epidemiology and laboratory capacity of the existing EIP network. PPACA funding will be used by the Oregon Public Health Division to enhance support for the basic infrastructure of the EIP network, currently in place in Oregon. These funds will serve to support personnel currently working on EIP-related projects, offer training and education to various stakeholders, expand on the information technology and exchange efforts within our state and nationally, as well as enhance surveillance for influenza & hospital-associated infections within our state.

描述（由申请人提供）：CDC的10个州新发感染项目（EIP）的目的是开展超出大多数卫生部门常规职能的监测和流行病学研究，回答国家公共卫生重要性的问题，并培训未来的流行病学家。《负担得起的医疗法案》资金的目的是支持和扩大现有EIP站点的能力，并启动与流感和卫生保健获得性感染（HAIs）有关的新项目。PPACA的资金将由俄勒冈州公共卫生部门用于加强对目前在俄勒冈州到位的EIP网络基础设施的支持。这些资金将用于支持目前从事知识产权相关项目的人员，为各种利益相关者提供培训和教育，扩大我们州和全国范围内的信息技术和交流工作，并开展新项目。具体而言，资金将用于4个重点领域：1)雇用额外的3.0名全职员工来支持多项EIP活动。2)获得有关监测和流行病学领域的教育和培训，即感染控制和健康信息。多达8名环境保护方案人员将接受感染控制方面的额外教育和培训，多达15名环境保护方案人员将接受卫生信息实践方面的高级教育和培训。3)支持信息技术，以便从波特兰大都会地区的血液透析中心获取有关血液感染的数据。4)聘用1.75名专职人员，加强与禽流感和流感有关的一般流行病学和实验室能力。俄勒冈州的EIP将致力于建立血液感染监测的评估和验证标准。此外，利用聚合酶链反应（PCR）对波特兰市EIP集水区住院流感患者分离物进行分型/分亚型，将增强俄勒冈州流感流行病学和实验室能力。此外，EIP流感项目将开展一项研究，以完善俄勒冈州的流感负担预测。新的利益相关方将是血液透析中心，这些中心将被要求向ACDP提交阳性血流感染通知。该资助机会所采取的所有其他努力将用于维持和加强长期EIP利益相关者（即俄勒冈州公共卫生实验室）目前的做法。拟议的新人员配备将包括1.0名FTE监督研究分析师-4；2.5 FTE研究分析师2；1.0 FTE行政专员-2；和0.25 FTE微生物学家2。PPACA EIP的资助进一步推动了OHA的使命，即通过加强传染病监测系统来保持俄勒冈人的健康和安全，该系统促进了对疫情的早期识别，并提高了确定重点、制定政策和预防和控制传染病所需的数据质量。大多数EIP项目不构成人体受试者研究。对于任何涉及人体研究的项目，俄勒冈州的EIP计划将向俄勒冈州公共卫生部门机构审查委员会提交协议。汇总数据（即没有患者标识符）将与疾病预防控制中心共享，并通过具有公共卫生价值的地方和国家出版物共享。